Topics

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

20:00 EDT 27 Oct 2019 | NEJM

npj Breast Cancer, Published online: 28 October 2019; doi:10.1038/s41523-019-0132-8

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

Original Article: Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

NEXT ARTICLE

More From BioPortfolio on "Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients"

Quick Search

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...